Evaluation of Using Iliac Crest With and Without Platelet-Rich Fibrin in Repair of Congenital Alveolar Cleft
Clinical and Radiographic Evaluation of Using Iliac Crest Graft With and Without Platelet-Rich Fibrin (PRF) in Repair of Congenital Alveolar Cleft
1 other identifier
interventional
16
1 country
1
Brief Summary
A randomized clinical trial aims to evaluate the clinical and radiographic outcomes of the repair of congenital alveolar clefts using Iliac crest graft with and without mixing with platelet-rich fibrin
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2024
CompletedFirst Submitted
Initial submission to the registry
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
April 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedApril 11, 2025
April 1, 2025
1.1 years
March 12, 2025
April 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in bucco-lingual thickness of the bone at the recipient site
Post-operative cone beam computed tomographic radiographs will be done using the Scanora 3DX imaging system using a CMOS flat panel detector with isotropic voxel size 133 µm. The x-ray tube that is used to scan the patients possesses a current intensity of 10 mA, 90 KVp, and a focal spot size of 0.5 mm. The scanning time is 14 seconds of pulsed exposure, resulting in an effective exposure time of 3.2 seconds to scan FOV (field of view) of 14 cm height × 16.5 cm width. The raw DICOM data set images will be imported to the On-Demand software (Cybermed, Seoul, Korea) for secondary reconstruction and image analysis. CBCT will be performed, and linear measurements will be obtained in axial, sagittal, and coronal cuts to assess the changes in buccolingual thickness of the bone at the recipient site 3 months and 6 months post-operatively.
3 months and 6 months postoperatively
Secondary Outcomes (2)
Calculation of the volume of bone fill in the recipient site
6 months postoperative
wound dehiscence
immediate, 7 days and 14 days postoperative
Study Arms (2)
with platelet-rich fibrin
EXPERIMENTALstudy group: the patients will be treated with iliac crest bone graft with platelet-rich fibrin
without Platelet-rich fibrin
ACTIVE COMPARATORcontrol group : the patients will be treated with iliac crest bone graft only
Interventions
cancellous iliac crest bone will be harvested following the usual surgical procedure. For patients of group a-PRF, it was mixed with 1 cc of the supernatant previously collected, in order to obtain a cohesive bone graft, easier to manipulate. The oral mucosal lining will be closed, and a membrane of PRF (PRF group) will be put over the suture line. The alveolar cleft will be then filled with cancellous iliac crest bone along its entire height. A new membrane of PRF will be placed over the bone graft, in order to enclose and protect it. Finally, muco-periosteal flaps will be advanced and sutured without tension over the alveolar crest
the PRF group: centrifugation at 1300 rpm during 5 minutes, collection of 1 cc of the supernatant, and centrifugation at 1300 rpm during 3 minutes. Careful removal of the clot and separation from the red blood cell fraction with scissors. the Platelet-rich fibrin will be added to the surgical site mixed with the iliac crest bone graft and it will also be used as a membrane before closure of the mucoperiosteal flap
Eligibility Criteria
You may qualify if:
- Patients with congenital alveolar cleft who need secondary alveolar cleft repair.
- Patients who are medically fit for surgery under general anaesthesia
You may not qualify if:
- ASA 4 OR ASA 5 patients
- Uncooperative patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Suez Canal University
Ismailia, 41522, Egypt
Related Publications (1)
Bayerlein T, Proff P, Heinrich A, Kaduk W, Hosten N, Gedrange T. Evaluation of bone availability in the cleft area following secondary osteoplasty. J Craniomaxillofac Surg. 2006 Sep;34 Suppl 2:57-61. doi: 10.1016/S1010-5182(06)60013-9.
PMID: 17071393BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohamed S Hamed, professor
Suez Canal University
- STUDY DIRECTOR
Osama Antar, professor
Suez Canal University
- STUDY DIRECTOR
Mohamed A Elsholkamy, professor
Suez Canal University
- STUDY DIRECTOR
Mohamed Nageh, Dr
Suez Canal University
- PRINCIPAL INVESTIGATOR
Aliaa E Ebrahim
Suez Canal University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2025
First Posted
April 11, 2025
Study Start
April 27, 2024
Primary Completion
June 1, 2025
Study Completion
December 1, 2025
Last Updated
April 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share